Home > PE Ratio > PANACEA BIOTEC

PANACEA BIOTEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of PANACEA BIOTEC is -69.57.

Share Price ₹138.4Apr 23,2024
Market Cap ₹848.1 Cr
Earnings-TTM₹-12.2 CrTTM-Consolidated Results
Price/Earnings-69.57xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results
PANACEA BIOTEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of PANACEA BIOTEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of PANACEA BIOTEC is calculated as :

Current Market Cap [ ₹848.1 Cr] as on Apr 23,2024

(/) Earnings [ ₹-12.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ -69.57x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for PANACEA BIOTEC , the investors are currently willing to pay -69.57 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANACEA BIOTEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of PANACEA BIOTEC over the last five years.

Historical PE (Price/Earnings) ratio chart of PANACEA BIOTEC


PE Ratio Performance Analysis for PANACEA BIOTEC

- PANACEA BIOTEC 's latest p/e ratio is -69.57x.

- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 6.60x.

- PANACEA BIOTEC 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2019 at 32.18x.

- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does PANACEA BIOTEC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
PANACEA BIOTEC -12.19-69.57848.1
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6339.56356,001.0
CIPLA LTD3,744.0329.06108,813.0
DR REDDYS LABORATORIES LTD5,209.4019.0799,325.3
ZYDUS LIFESCIENCES LTD2,954.2032.6896,553.2
DIVIS LABORATORIES LTD1,382.9772.36100,075.0
MANKIND PHARMA LTD1,743.3055.0195,896.9
TORRENT PHARMACEUTICALS LTD1,494.0059.7289,224.4
LUPIN LTD1,809.7439.8072,033.6
AUROBINDO PHARMA LTD2,777.8923.0564,043.1
ABBOTT INDIA LTD1,145.5847.7554,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANACEA BIOTEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -69.57x
Max industry PE 72.36x
Median industry PE 39.56x
Average industry PE 31.68x



You may also like the below Video Courses